These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 3783128

  • 1. The effect of pH on the early interaction of West Nile virus with P388D1 cells.
    Kimura T, Gollins SW, Porterfield JS.
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2423-33. PubMed ID: 3783128
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Survival of mice immunized with monoclonal antibodies against glycoprotein E of Japanese encephalitis virus before or after infection with Japanese encephalitis, West Nile, and Dengue viruses.
    Gupta AK, Lad VJ, Koshy AA.
    Acta Virol; 2008 Nov; 52(4):219-24. PubMed ID: 19143477
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus.
    Throsby M, Geuijen C, Goudsmit J, Bakker AQ, Korimbocus J, Kramer RA, Clijsters-van der Horst M, de Jong M, Jongeneelen M, Thijsse S, Smit R, Visser TJ, Bijl N, Marissen WE, Loeb M, Kelvin DJ, Preiser W, ter Meulen J, de Kruif J.
    J Virol; 2006 Jul; 80(14):6982-92. PubMed ID: 16809304
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
    Raux H, Coulon P, Lafay F, Flamand A.
    Virology; 1995 Jul 10; 210(2):400-8. PubMed ID: 7542418
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
    Ledizet M, Kar K, Foellmer HG, Bonafé N, Anthony KG, Gould LH, Bushmich SL, Fikrig E, Koski RA.
    J Infect Dis; 2007 Dec 15; 196(12):1741-8. PubMed ID: 18190253
    [Abstract] [Full Text] [Related]

  • 18. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, Price A, Jacobs A, Takahashi VN, Huang Y, Nakaar V, Alexopoulou L, Fikrig E, Powell TJ.
    J Infect Dis; 2007 Jun 01; 195(11):1607-17. PubMed ID: 17471430
    [Abstract] [Full Text] [Related]

  • 19. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
    Schneeweiss A, Chabierski S, Salomo M, Delaroque N, Al-Robaiy S, Grunwald T, Bürki K, Liebert UG, Ulbert S.
    Vaccine; 2011 Aug 26; 29(37):6352-7. PubMed ID: 21596075
    [Abstract] [Full Text] [Related]

  • 20. [Immunochemical properties of short recombinant polypeptides of proteine of, the West Nile virus bearing epitopes of domains I and II].
    Bogachek MV, Protopopova EV, Ternovoĭ VA, Kachko AV, Ivanova AV, Ivanisenko VA, Loktev VB.
    Mol Biol (Mosk); 2005 Aug 26; 39(5):813-22. PubMed ID: 16240715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.